메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 33, Issue 21, 2015, Pages 2408-2409
Reply to J.N. Primrose et al and C.-H. Köhne
Author keywords

[No Author keywords available]
Indexed keywords

CETUXIMAB; OXALIPLATIN; ANTINEOPLASTIC AGENT; RAS PROTEIN;
EID: 84940570073     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.4751     Document Type: Letter
Times cited : (3)
References (4)
  • 1
    • 84940366697 scopus 로고    scopus 로고
    • Cetuximab is contraindicated in the perioperative treatment of colorectal liver metastases
    • Primrose J, Cunningham D, Garden OJ, et al: Cetuximab is contraindicated in the perioperative treatment of colorectal liver metastases. J Clin Oncol 33:2405-2406, 2015
    • (2015) J Clin Oncol , vol.33 , pp. 2405-2406
    • Primrose, J.1    Cunningham, D.2    Garden, O.J.3
  • 2
    • 84899900161 scopus 로고    scopus 로고
    • Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: The New EPOC randomised controlled trial
    • Primrose J, Falk S, Finch-Jones M, et al: Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: The New EPOC randomised controlled trial. Lancet Oncol 15:601-611, 2014
    • (2014) Lancet Oncol , vol.15 , pp. 601-611
    • Primrose, J.1    Falk, S.2    Finch-Jones, M.3
  • 3
    • 84940388245 scopus 로고    scopus 로고
    • Is progression-free survival the right end point in trials of patients with clearly resectable, borderline resectable, and unresectable liver-limited colorectal cancer?
    • Köhne C-H: Is progression-free survival the right end point in trials of patients with clearly resectable, borderline resectable, and unresectable liver-limited colorectal cancer? J Clin Oncol 33:2406-2408, 2015
    • (2015) J Clin Oncol , vol.33 , pp. 2406-2408
    • Köhne, C.-H.1
  • 4
    • 84921764691 scopus 로고    scopus 로고
    • Should the results of the New EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver?
    • Nordlinger B, Poston GJ, Goldberg RM: Should the results of the New EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver? J Clin Oncol 33:241-243, 2014
    • (2014) J Clin Oncol , vol.33 , pp. 241-243
    • Nordlinger, B.1    Poston, G.J.2    Goldberg, R.M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.